Literature DB >> 9709467

Outcome from a rapid-assessment chest pain clinic.

A P Davie1, D Caesar, L Caruana, G Clegg, J Spiller, S Capewell, I R Starkey, T R Shaw, J J McMurray.   

Abstract

Chest pain accounts for much of the rising numbers of emergency admissions, but in-patient assessment is not necessarily the best way of dealing with these patients. We ran a 'rapid-assessment chest pain clinic' to provide an alternative route of assessment, and audited its outcome. General practitioners referred patients with recent-onset chest pain, increasing chest pain, chest pain at rest, or other chest pain of concern, on the understanding that they would be seen within 24 h. During 8 1/2 months, 334 patients were referred and 317 patients were seen, most of whom had exercise electrocardiography. A median of 6 months later, 278 patients were personally contacted to determine outcome. Of these, 18% had been admitted immediately with acute coronary syndromes, and 49% had been diagnosed as non-coronary chest pain (none of whom subsequently infarcted or died). Continuing symptoms were infrequent, and satisfaction was high, although 13% of patients had been revascularized. A significant number of patients required immediate admission and/or ultimate revascularization, but many more did not. The majority of these patients had non-coronary chest pain, and this diagnosis was substantiated by their excellent outcome and (in some cases) by further investigation.

Entities:  

Mesh:

Year:  1998        PMID: 9709467     DOI: 10.1093/qjmed/91.5.339

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  8 in total

Review 1.  Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. British Cardiac Society Guidelines and Medical Practice Committee and Royal College of Physicians Clinical Effectiveness and Evaluation Unit.

Authors: 
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 2.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

3.  How effective are rapid access chest pain clinics? Prognosis of incident angina and non-cardiac chest pain in 8762 consecutive patients.

Authors:  N Sekhri; G S Feder; C Junghans; H Hemingway; A D Timmis
Journal:  Heart       Date:  2006-06-21       Impact factor: 5.994

4.  Emergency medical admissions in Glasgow: general practices vary despite adjustment for age, sex, and deprivation.

Authors:  O Blatchford; S Capewell; S Murray; M Blatchford
Journal:  Br J Gen Pract       Date:  1999-07       Impact factor: 5.386

5.  Short-term and long-term outcomes in 133,429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990-2000: population-based cohort study.

Authors:  S Capewell; N F Murphy; K MacIntyre; S Frame; S Stewart; J W T Chalmers; J Boyd; A Finlayson; A Redpath; J J V McMurray
Journal:  Heart       Date:  2006-06-14       Impact factor: 5.994

6.  An audit of activity and outcome from a daily and a weekly "one stop" rapid assessment chest pain clinic.

Authors:  J Byrne; D Murdoch; C Morrison; J McMurray
Journal:  Postgrad Med J       Date:  2002-01       Impact factor: 2.401

7.  A rapid access cardiology service for chest pain, heart failure and arrhythmias accurately diagnoses cardiac disease and identifies patients at high risk: a prospective cohort study.

Authors:  J N Tenkorang; K F Fox; T J Collier; D A Wood
Journal:  Heart       Date:  2005-12-30       Impact factor: 5.994

8.  Pre-hospital ECG for acute coronary syndrome in urban India: a cost-effectiveness analysis.

Authors:  Joshua Schulman-Marcus; Dorairaj Prabhakaran; Thomas A Gaziano
Journal:  BMC Cardiovasc Disord       Date:  2010-03-12       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.